ADC Therapeutics S.A. (ADCT)
Market Closed
1 Sep, 20:00
NYSE NYSE Primary $
1. 24
+0.07
+5.9829%
$
122.75M Market Cap
- P/E Ratio
- Div Yield
1.15M Volume
-2.35 Eps
$ 1.17
Previous Close 
Want to track ADCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ADC Therapeutics S.A. (ADCT) Statistics
Valuation metrics
Market Cap 122.75M
Enterprise value 343M
Trailing P/E (ttm) -1.72
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) 1.84
Price/Book (mrq) -0.77
Enterprise Value/Revenue 4.35
Enterprise Value/EBITDA -3.92
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.4M
Average volume (90 days) 4.62M
Price summary
52-Week low 0.78
52-Week high 4.98
Beta -
50-Day moving average 1.12
200-Day moving average 3.68
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.23%
Operating margin -1.26%
Operational effectiveness
Return on assets -0.35%
Return on equity 0.45%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.51
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.63
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.41
Total debt (mrq) -
Total Debt/Equity (mrq) -1.83
Current ratio (mrq) 3.03%
Book value per share (mrq) -1.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
